Cargando…
Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus
SUMMARY: In contrast to previously reported elevations in serum sclerostin levels in diabetic patients, the present study shows that the impaired bone microarchitecture and cellular turnover associated with type 2 diabetes mellitus (T2DM)-like conditions in ZDF rats are not correlated with changes i...
Autores principales: | Pereira, M., Gohin, S., Lund, N., Hvid, A., Smitham, P. J., Oddy, M. J., Reichert, I., Farlay, D., Roux, J. P., Cleasby, M. E., Chenu, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206261/ https://www.ncbi.nlm.nih.gov/pubmed/27468901 http://dx.doi.org/10.1007/s00198-016-3718-0 |
Ejemplares similares
-
Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
por: Pereira, Marie, et al.
Publicado: (2017) -
Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis
por: Vasiliadis, Elias S., et al.
Publicado: (2021) -
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
por: Jeyabalan, J., et al.
Publicado: (2013) -
The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide‐mediated vasorelaxation in BALB/c mice
por: Gohin, S, et al.
Publicado: (2016) -
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)